Abstract

Objective:To report on the results of a standardised consensus process agreeing on concepts typical and/or relevant when classifying functioning and health in patients with ankylosing spondylitis (AS) based on the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Content validity of the Brief and Comprehensive ICF Core Sets for common disabling conditions in a developing country.
Haxby J Abbott ... Anupa Pathak
International journal of rehabilitation research. Internationale Zeitschrift fur Rehabilitationsforschung. Revue internationale de recherches de readaptation | VOL. 44
Haxby J Abbott, et. al.Haxby J Abbott ... Anupa Pathak
01 Jun 2021
SAT0270 COMPREHENSIVE ICF CORE SET AND ICF-BASED QUESTIONNAIRE ASSESSING ACTIVITIES AND PARTICIPATION IN PATIENTS WITH SYSTEMIC SCLEROSIS: THE SCISCIF STUDY
Christelle Nguyen ... Luc Mouthon
-
Christelle Nguyen, et. al.Christelle Nguyen ... Luc Mouthon
01 Jun 2019
Comprehensive icf core set and icf core set-derived activities and participation questionnaire for patients with systemic sclerosis: Results of the SCISCIF study
S Poiraudeau ... C Daste
Annals of Physical and Rehabilitation Medicine | VOL. 61
S Poiraudeau, et. al.S Poiraudeau ... C Daste
01 Jul 2018
OP0251 Development of a health index to assess the burden of disease in patients with ankylosing spondylitis – first steps of a global initiative based on the ICF guided by ASAS
U Kiltz ... D Van Der Heijde
Annals of the Rheumatic Diseases | VOL. 71
U Kiltz, et. al.U Kiltz ... D Van Der Heijde
01 Jun 2013
View more papers

More From: Annals of the Rheumatic Diseases

Paper Title
Journal
Date
Author
The associations between poorer pain-related health status and increased hospitalisations and excess mortality in patients with rheumatoid arthritis (RA): a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD)
Huai Leng Pisaniello ... Samuel Lawrance Whittle
Annals of the Rheumatic Diseases | VOL. -
Huai Leng Pisaniello, et. al.Huai Leng Pisaniello ... Samuel Lawrance Whittle
29 May 2024
Integrated safety analysis of filgotinib in patients with moderate-to-severe rheumatoid arthritis over a treatment duration of up to 8.3 years
Gerd R Burmester ... Daniel Aletaha
Annals of the Rheumatic Diseases | VOL. -
Gerd R Burmester, et. al.Gerd R Burmester ... Daniel Aletaha
23 May 2024
BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial
Weijia Wang ... Yong Yuan
Annals of the Rheumatic Diseases | VOL. -
Weijia Wang, et. al.Weijia Wang ... Yong Yuan
22 May 2024
Exploring the effect on primary endpoints in trials testing targeted therapy interventions for rheumatoid arthritis: a meta-epidemiological study on the appropriate use of a core outcome set
Philip Rask Lage-Hansen ... Robin Christensen
Annals of the Rheumatic Diseases | VOL. -
Philip Rask Lage-Hansen, et. al.Philip Rask Lage-Hansen ... Robin Christensen
22 May 2024
View more papers